Brief: Alligator Bioscience Announces Positive Safety Data
Sept 30 (Reuters) - Alligator Bioscience AB ATORX.ST :
* ANNOUNCES POSITIVE SAFETY DATA FROM 900 MG DOSE COHORT IN
ATOR-1017 PHASE 1 DOSE ESCALATION STUDY IN PATIENTS WITH
ADVANCED SOLID MALIGNANCIES
* ATOR-1017 DEMONSTRATED SAFETY AND TOLERABILITY AT DOSES UP
TO
900 MG
Source text for Eikon: ID:nMFNl8GBL
Further company coverage: ATORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue